0
0
New Delhi, June 13 (IANS) — Healthcare professionals across the globe are expressing strong enthusiasm for the adoption of generative artificial intelligence (GenAI) to address pressing challenges such as workforce shortages, burnout, rising costs, and growing administrative burdens, according to a new report from Wolters Kluwer Health. Despite this optimism, most healthcare organisations are not yet ready to fully harness the technology’s potential.
The report, based on a survey of physicians, nurses, pharmacists, allied health professionals, and administrators, highlights a significant gap between organisational aspirations for GenAI and the readiness to implement it. While 80% of respondents identified “optimising workflows” as a top goal, only 63% feel prepared to use GenAI to achieve this objective. This disconnect underscores the challenges facing healthcare systems as they seek to modernise and improve efficiency.
GenAI is seen as a promising solution for longstanding issues in healthcare, including managing prior authorisations (cited by 67% of respondents), electronic health record (EHR) management (62%), cybersecurity preparedness (68%), and supporting telehealth and virtual care programmes (65%). However, the report reveals that only 18% of survey participants are aware of formal organisational policies governing GenAI use, and just one in five have received structured training on the technology.
Concerns also persist about the impact of GenAI on clinical decision-making. More than half (57%) of respondents worry that overreliance on GenAI could erode clinical skills, while 55% are concerned that a lack of transparency in how GenAI informs diagnoses may lead to unclear reasoning behind patient-facing decisions.
Greg Samios, CEO of Wolters Kluwer Health, emphasised the transformative potential of GenAI: “GenAI has the potential to be a powerful tool for supporting sustainability in healthcare organisations right now, as well as preparing them for a more efficient future.” He added that organisations risk falling behind unless they adopt a more cohesive approach to making GenAI standardised, scalable, and impactful.
Disclaimer:
This news article is based on information sourced from IANS and a report by Wolters Kluwer Health. The views and opinions expressed herein are for informational purposes only and do not constitute professional or medical advice. Readers are encouraged to consult relevant experts for guidance on healthcare technology adoption and its implications.
